title: Cost-Minimization Analysis of Trastuzumab Intravenous Versus Trastuzumab Subcutaneous for the Treatment of Patients With HER2+ Early Breast Cancer And Metastatic Breast Cancer in Greece.
authors.affiliation: National School of Public Health, Athens, Greece.
authors.forename: C
authors.initials: C
authors.lastname: Mylonas
authors.affiliation: Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens, Greece.
authors.forename: G
authors.initials: G
authors.lastname: Kourlaba
authors.affiliation: Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece.
authors.forename: G
authors.initials: G
authors.lastname: Fountzilas
authors.affiliation: Roche (Hellas) S. A., Athens, Greece.
authors.forename: A
authors.initials: A
authors.lastname: Skroumpelos
authors.affiliation: National School of Public Health, Athens, Greece.
authors.forename: N
authors.initials: N
authors.lastname: Maniadakis